Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE)

CAPS Rating: 1 out of 5

Caps

How do you think ZYNE will perform against the market?

Add Stock to CAPS Watchlist

All Players

21 Outperform
19 Underperform
 

All-Star Players

7 Outperform
17 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top ZYNE Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TheMrJones (< 20)
Submitted January 18, 2017

Cannabis and Biotech collide, something that many will be watching but it all comes down to legislation so things are still a bit uncertain.

jed71 (99.83)
Submitted September 30, 2016

If you think all marijuana companies are the same, you might be right. I am starting to be convinced of the same. When I first started researching here, I was pretty sure this was a legitimate attempt to start a new drug company. The more I read, the… More

ZYNE VS S&P 500 (SPY)

ZYNE Summary

Recent Community Commentary

Read the most recent pitches from players about ZYNE.

Recs

0
Member Avatar TerryHogan (99.97) Submitted: 9/28/2018 2:19:31 AM : Underperform Start Price: $8.01 ZYNE Score: +30.37

It's got a name that looks like it was created by a committee of intoxicated pharmacists, and it's burning cash like a pyromaniac in a Parker Brothers factory. Red Thumb. Of course there's always the neo-crypto marijuana enthusiasts who can bid up anything, so it's not without danger.

Recs

0
Member Avatar Bigsef77 (69.42) Submitted: 9/21/2018 10:03:42 AM : Outperform Start Price: $19.40 ZYNE Score: -83.16

Is the Options Market Predicting a Spike in Zynerba Pharmaceuticals (ZYNE) Stock?
Zacks
Zacks Equity Research
,Zacks•September 20, 2018
Investors in Zynerba Pharmaceuticals, Inc. ZYNE need to pay close attention to the stock based on moves in the options market lately. That is because the Sep 21, 2018 $7.50 Call had some of the highest implied volatility of all equity options today.

What is Implied Volatility?

Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.

What do the Analysts Think?

Clearly, options traders are pricing in a big move for Zynerba Pharmaceuticals shares, but what is the fundamental picture for the company? Currently, Zynerba Pharmaceuticals is a Zacks Rank #4 (Sell) in the Medical - Generic Drugs industry that ranks in the Top 40% of our Zacks Industry Rank. Over the last 60 days, our Zacks Consensus Estimate for the current quarter has narrowed from a loss of 72 cents per share to a loss of 66 cents.

Given the way analysts feel about Zynerba Pharmaceuticals right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.

Recs

1
Member Avatar TheMrJones (< 20) Submitted: 1/18/2017 10:31:11 AM : Outperform Start Price: $20.69 ZYNE Score: -93.94

Cannabis and Biotech collide, something that many will be watching but it all comes down to legislation so things are still a bit uncertain.

Leaderboard

Find the members with the highest scoring picks in ZYNE.

Score Leader

zzlangerhans

zzlangerhans (99.86) Score: +173.76

This was probably the most ludicrous move of 2016 so far.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
gcaderas 79.01 4/18/2017 Underperform 5Y $24.47 -79.81% +14.21% +94.02 0 Comment
evergreen5555 74.25 4/18/2017 Underperform 5Y $24.15 -79.54% +14.08% +93.63 0 Comment
jed71 99.83 9/30/2016 Underperform 5Y $12.90 -61.71% +23.81% +85.51 2 Comments
TMFBabo 100.00 10/26/2016 Underperform 5Y $11.23 -56.01% +24.69% +80.70 0 Comment
antigrowth 97.31 2/13/2018 Underperform 5Y $11.50 -57.04% +1.12% +58.16 0 Comment
401ktimer1 98.83 10/17/2017 Underperform 5Y $9.28 -46.77% +4.56% +51.33 0 Comment
anchak 99.90 9/29/2017 Underperform NS $8.89 -44.43% +6.55% +50.98 0 Comment
RyanIdaho 95.69 7/3/2018 Underperform 5Y $9.67 -48.91% -2.18% +46.73 0 Comment
DrDoofenshmirtz 99.82 9/21/2018 Underperform 5Y $8.51 -41.95% -8.83% +33.13 0 Comment
TerryHogan 99.97 9/28/2018 Underperform 5Y $8.01 -38.33% -7.96% +30.37 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ZYNE.

Advertisement